BioMed Research International / 2016 / Article / Tab 1

Research Article

Subclinical Hypothyroidism in PCOS: Impact on Presentation, Insulin Resistance, and Cardiovascular Risk

Table 1

Characteristics of study population.

VariablePCOS ()
(mean ± SD)
Control ()
(mean ± SD)
value

Age (years)27.4 ± 5.423.3 ± 4.1NS
BMI (Kg/m2)31.2 ± 8.329.2 ± 5.1NS
Hypertension (%)18 ()5 ()<0.001
Hirsutism (%)76 ()13 ()<0.001
Ferriman and Gallwey score19.31 ± 9.78.32 ± 4.8<0.001
LH (mIU/mL)12.72 ± 4.910.19 ± 4.1<0.001
FSH (mIU/mL)5.01 ± 2.14.26 ± 2.10.01
LH/FSH ratio2.7 ± 0.81.05 ± 1.02<0.01
Free T3 (pg/mL)2.61 ± 1.43.48 ± 0.80.03
Free T4 (ng/dL)1.17 ± 1.21.21 ± 2.9NS
TSH (mIU/mL)5.11 ± 22.72.9 ± 3.2<0.001
Anti-TPO ab (IU/mL)76.23 ± 23.420.14 ± 12.4<0.001
Free testosterone (pg/mL)21.13 ± 9.212.4 ± 6.1<0.001
Estradiol (pg/mL)62.21 ± 31.667.34 ± 45.21NS
Progesterone (ng/mL)2.4 ± 1.89.1 ± 5.2<0.001
HOMA-IR3.6 ± 1.71.7 ± 1.0<0.001
Hypoechoic USG (%)34 ()7 ()<0.01
Total cholesterol (mg/dL)232 ± 31.4172 ± 26.70.02
Triglycerides (mg/dL)124 ± 21.386.9 ± 12.40.01
LDL Chol. (mg/dL)143 ± 19.7112 ± 26.10.01
HDL Chol. (mg/dL)39.4 ± 17.356.9 ± 6.70.01

; statistically significant.

You are browsing a BETA version of Hindawi.com. Click here to switch back to the original design.